CClinicalTrials.gg
Active, not recruitingNCT06778148Updated Jan 20, 2025

Abridge AI Pilot Test

An interventional study of Ambient AI for clinician documentation in Clinician Experience and Clinician Burnout, sponsored by University of Colorado, Denver. Active, not recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2025-01-20.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 2 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
232
Allocation
Randomized
Sex
All
01

Study summary

We are piloting a new technology (Abridge) that uses artificial intelligence to listen to clinician-patient office visits and then document the interaction in the electronic health record.

Read the detailed description

This study will evaluate pilot implementation of the Abridge Artificial Intelligence (AI) Platform (Abridge) in UCHealth clinics. Abridge licenses will be deployed to 116 physician and advanced practice clinicians to accomplish the following goals:

  1. Determine if Abridge meaningfully impacts clinician documentation time and burnout or stress
  2. Determine whether to scale Abridge beyond the pilot

We will evaluate clinician experiences using Abridge, particularly with regard to documentation time and clinician burnout or stress. Study findings will explore value added in integrating Abridge into clinician practice, and guide decision-making for entering into a commercial agreement with Abridge. This pilot will also inform best practices for scaling Abridge to a broader user base across UCHealth outpatient practices.

02

Conditions studied

  • Clinician Experience
  • Clinician Burnout

Keywords

  • Ambient AI
  • Clinician burnout
03

In context

Burnout, Psychological

442 studies on the registry are indexed under Burnout, Psychological; 106 are open to participants now.

This study's planned enrollment of 232 is above the median of 80 across 319 interventional studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

-clinician (physician, advance practice professional, or licensed mental health professional) employed by UCHealth

  • See clinic patients at least three half-day sessions per week. (Half-day sessions seeing or supervising patients with residents and fellows will NOT count toward the weekly total. Half-day sessions seeing patients with a medical student CAN count toward the weekly total, however, Abridge can only capture conversations where you are physically present with patients.)
  • Own an iOS smartphone and be willing to download and use the Epic Haiku smartphone app during clinic visits

Exclusion criteria

Exclusion Criteria:

  • Trainees including residents and fellows
  • PT/OT, ED, maternal/fetal, pediatric, dental, eye specialties
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
232 participants (estimated)

Study arms

  • Experimental
    Assigned Abridge license

    Providers assigned a license

    Other: Ambient AI for clinician documentation

  • No intervention
    Control

    Providers not assigned a license or waitlisted

Interventions

  • OtherAmbient AI for clinician documentation

    Ambient AI for clinician documentation

    Also known as: Abridge

06

What researchers measure

Primary outcomes

  1. Burnout - High emotional exhaustion

    Validated measure collected by survey. Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC3475833/

    Time frame: Baseline, 2, 4 and 8 months

  2. Burnout - High depersonalization

    Validated measure collected by survey. Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC3475833/

    Time frame: Baseline, 2, 4 and 8 months

  3. Burnout - emotional exhaustion and depersonalization

    Validated measure collected by survey. Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC3475833/

    Time frame: Baseline, 2, 4 and 8 months

  4. Time in notes per appointment

    Collected via EHR signal data

    Time frame: Baseline, 2, 4 and 8 months

  5. Adoption

    Percent of eligible visits in which intervention is used. Collected via EHR data

    Time frame: 2, 4 and 8 months

Secondary outcomes

  1. Reach

    Proportion and representativeness of eligible patients and visits intervention was used for

    Time frame: 2, 4 and 8 months

  2. Clinician experience

    Likelihood to recommend via validated NPS, qualitative drivers of experience, likelihood to change jobs, Weiners feasiblity/implementability/acceptability, system usability scale

    Time frame: Baseline, 2, 4 and 8 months

  3. Time documenting

    Time spent documenting beyond appointment, average time in the EHR, time of last log out of the day, pajama time documenting

    Time frame: Baseline, 2, 4 and 8 months

  4. Operational efficiency

    Same day note closure, average note star rating, average note turn around time

    Time frame: Baseline, 2, 4 and 8 months

  5. Adoption

    Abandonment rate and representativeness

    Time frame: 2, 4 and 8 months

07

Study locations

1 site
  • UCHealth
    Aurora, Colorado 80045, United States
08

References and documents

Individual participant data

Plan to share: No — Unsure if the third party owner of Abridge will allow sharing

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06778148
Lead sponsor
University of Colorado, Denver
Responsible party
Sponsor
First posted
Jan 16, 2025
Start date
Jan 13, 2025
Primary completion
Jul 13, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jan 20, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion